Diabetes mellitus and the occurrence of colorectal cancer: An updated meta-analysis of cohort studies

Diabetes Technology and Therapeutics

Volumn 15, Issue 5, 2013, Pages 419-427

  Wu, Lei ^a   Yu, Chao ^a   Jiang, Han ^a   Tang, Jun ^b   Huang, He Lang ^a   Gao, Jing ^c   Zhang, Xin ^a  

^a NANCHANG UNIVERSITY   (China)

^b Cancer Hospital of Jiangxi   (China)

^c Drug Adverse Reaction Monitoring Center of Jiangxi   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; COMPUTER PROGRAM; DIABETES MELLITUS; EMBASE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLISHING; RELIABILITY; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 84877673863     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0263     Document Type: Article

References (61)

1. Chi JM: Practice of Diabetology, 3rd ed. Beijing: People's Medical Publishing House, 2009.
2. Alexander DD, Cushing CA: Red meat and colorectal cancer: A critical summary of prospective epidemiologic studies. Obes Rev 2011;12:e472-e493.
3. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R: A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 2007;4:e325.
4. English DR, MacInnis RJ, Hodge AM, Hopper JL, Haydon AM, Giles GG: Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1509-1514.
5. Ryan-Harshman M, Aldoori W: Diet and colorectal cancer: Review of the evidence. Can Fam Physician 2007;53: 1913-1920.
6. Lin J, Zhang SM, Cook NR, Rexrode KM, Liu S, Manson JE, Lee IM, Buring JE: Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States). Cancer Causes Control 2005;16: 225-233.
7. Wakai K, Hayakawa N, Kojima M, Tamakoshi K, Watanabe Y, Suzuki K, Hashimoto S, Tokudome S, Toyoshima H, Ito Y, Tamakoshi A; JACC Study Group: Smoking and colorectal cancer in a non-Western population: A prospective cohort study in Japan. J Epidemiol 2003;13:323-332.
8. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, Negri E, Straif K, Romieu I, La Vecchia C, Boffetta P, Jenab M: Alcohol drinking and colorectal cancer risk: An overall and dose-response meta-analysis of published studies. Ann Oncol 2011;22:1958-1972.
9. Chan AT, Giovannucci EL: Primary prevention of colorectal cancer. Gastroenterology 2010;138:2029-2043.e10.
10. Anzuini F, Battistella A, Izzotti A: Physical activity and cancer prevention: A review of current evidence and biological mechanisms. J Prev Med Hyg 2011;52:174-180.
11. Harriss DJ, Atkinson G, Batterham A, George K, Cable NT, Reilly T, Haboubi N; Colorectal Cancer, Lifestyle, Exercise And Research Group: Lifestyle factors and colorectal cancer risk (2): A systematic review and meta-analysis of associations with leisure-time physical activity. Colorectal Dis 2009; 11:689-701.
12. McKeown-Eyssen G: Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-695.
13. Grant WB: Comments on E. Giovannucci, ''Insulin, insulinlike growth factors and colon cancer: A review of the evidence.'' J Nutr 2002;132:2324; author reply 2325.
14. Berster JM, Göke B: Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 2008;114:84-98.
15. Smith CJ, McKay GA, Fisher M: Diabetes, colorectal cancer and cyclooxygenase 2 inhibition. Int J Clin Pract 2008;62: 810-815.
16. Jin T: Why diabetes patients are more prone to the development of colon cancer? Med Hypotheses 2008;71:241-244.
17. Rizzo A, Pallone F, Monteleone G, Fantini MC: Intestinal inflammation and colorectal cancer: A double-edged sword? World J Gastroenterol 2011;17:3092-3100.
18. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD: Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-696.
19. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE, Giovannucci E: Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999;91:542-547.
20. Larsson SC, Giovannucci E, Wolk A: Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005;28:1805-1807.
21. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC: Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006;98:135-138.
22. Steenland K, Nowlin S, Palu S: Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: Diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995;4:807-811.
23. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ: Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-1154.
24. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, Stolzenberg-Solomon R: A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006;164:652-664.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Metaanalysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. JAMA 2000;283:2008- 2012.
26. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed June 19, 2012
27. Will JC, Galuska DA, Vinicor F, Calle EE: Colorectal cancer: Another complication of diabetes mellitus? Am J Epidemiol 1998;147:816-825.
28. Nilsen TI, Vatten LJ: Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001;84:417-422.
29. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Preliminary communication: Glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: A prospective analysis from the European Prospective Investigation into Cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 2004;13:915-919.
30. Limburg PJ, Anderson KE, Johnson TW, Jacobs DR Jr, Lazovich D, Hong CP, Nicodemus KK, Folsom AR: Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2005;14:133-137.
31. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
32. Stü rmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ: Metabolic abnormalities and risk for colorectal cancer in the Physicians' Health Study. Cancer Epidemiol Biomarkers Prev 2006;15:2391-2397.
33. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S: Diabetes mellitus and the risk of cancer: Results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006;166:1871-1877.
34. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, Tamakoshi A; Japan Collaborative Cohort Study Group: Site-specific cancer risk due to diabetes mellitus history: Evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 2006; 7:253-259.
35. Ahmed RL, Schmitz KH, Anderson KE, Rosamond WD, Folsom AR: The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006;107:28-36.
36. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK: Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006;49:945-952.
37. Folsom AR, Pankow JS, Peacock JM, Bielinski SJ, Heiss G, Boerwinkle E: Variation in TCF7L2 and increased risk of colon cancer: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2008;31:905-909.
38. Ogunleye AA, Ogston SA, Morris AD, Evans JM: A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009;101:1199-1201.
39. Flood A, Strayer L, Schairer C, Schatzkin A: Diabetes and risk of incident colorectal cancer in a prospective cohort of women. Cancer Causes Control 2010;21:1277-1284.
40. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA: The association of diabetes with colorectal cancer risk: The Multiethnic Cohort. Br J Cancer 2010;103: 120-126.
41. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A, Kokia E, Shalev V: Diabetes and risk of incident cancer: A large population-based cohort study in Israel. Cancer Causes Control 2010;21:879-887.
42. Campbell PT, Deka A, Jacobs EJ, Newton CC, Hildebrand JS, McCullough ML, Limburg PJ, Gapstur SM: Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men. Gastroenterology 2010;139:1138-1146.
43. Johnson JA, Bowker SL, Richardson K, Marra CA: Timevarying incidence of cancer after the onset of type 2 diabetes: Evidence of potential detection bias. Diabetologia 2011;54: 2263-2271.
44. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA: Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011;128:635-643.
45. Ragozzino M, Melton LJ 3rd, Chu CP, Palumbo PJ: Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-19.
46. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH: Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89: 1360-1365.
47. Weiderpass E, Gridley G, Nyre'n O, Ekbom A, Persson I, Adami HO: Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst. 1997;89:660-661.
48. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA, Patterson CC, Keen H: Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study. Br J Cancer 2005;92:2070-2075.
49. Hemminki K, Li X, Sundquist J, Sundquist J, Sundquist K: Risk of cancer following hospitalization for type 2 diabetes. Oncologist 2010;15:548-555.
50. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970;44:673-686.
51. Verlato G, Zoppini G, Bonora E, Muggeo M: Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 2003;26:1047-1051.
52. Bai JL, Zhong WZ, Zheng MH, Chen F: Meta-analysis in Stata. J Evid Based Med 2007;7:363-368.
53. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ: Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096-1103.
54. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K: Cancer risk among patients hospitalized for type 1 diabetes mellitus: A population-based cohort study in Sweden. Diabet Med 2010;27:791-797.
55. Smith U, Gale EA: Does diabetes therapy influence the risk of cancer? Diabetologia 2009;52:1699-1708.
56. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR: Longterm metformin use is associated with decreased risk of breast cancer. Diabetes Care 2010;33:1304-1308.
57. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-1101.
58. Berster JM, Göke B: Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 2008;114:84-98.
59. Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, Yeh YH, Su SC, Chen YC, Chen MK, Yang SF: Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol 2010;17:1808-1815.
60. Fernandez-Veledo S, Nieto-Vazquez I, Vila-Bedmar R, Garcia-Guerra L, Alonso-Chamorro M, Lorenzo M: Molecular mechanisms involved in obesity-associated insulin resistance: Therapeutical approach. Arch Physiol Biochem 2009;115:227-239.
61. Kajiura K, Ohkusa T, Okayasu I: Relationship between fecal bile acids and the occurrence of colorectal neoplasia in experimental murine ulcerative colitis. Digestion 1998;59:69-72.